InvestLens AI is the engagement that produces your board-ready AI investment strategy — or the due-diligence memo your investment committee needs on an AI-exposed target.
The stakes
Your board wants an AI strategy. Your CFO wants risk-adjusted numbers. Your peers are already deploying. Budget requests stack up, each one promising transformation. Without a framework to prioritize initiatives and stress-test the assumptions, Stage 1 decisions become Stage 2 write-offs.
Two failure modes. Most organisations discover both at the same time: pilots that produce no operational return, and pilots that do ship and then create regulatory or legal consequences. Neither outcome was in the business case that got approved.
Accountable executives are asked to approve AI investments they cannot fully evaluate. The Agentic Risk Score on every proposed initiative gives you a defensible, quantified record of the risk you accepted — so the board, the auditor, and the insurer can all read the same artifact.
Deal teams evaluating AI-exposed targets face a verification problem no generalist cyber diligence firm can answer. Is the claimed technology real or marketing? What is the data provenance? What regulatory or contractual landmines sit below the waterline? The diligence variant of InvestLens AI answers these in a 2–4 week window, at IC-grade.
Two use cases, one methodology
InvestLens AI serves two buyer contexts with the same assessment methodology, adapted for output format, timeline, and audience.
For operating companies deciding where to deploy AI capital.
You are the CEO, CFO, COO, or Board. You need a board-ready AI investment plan that prioritizes initiatives, stress-tests the assumptions, quantifies the risk on each bet, and sequences the rollout with go/no-go gates. A four-to-eight week engagement. A document your investment committee can approve.
For PE, growth equity, corporate M&A, R&W insurers, and family offices.
You are diligencing an AI-exposed target. You need fast turnaround, an IC-grade memo, and specific answers: Is the claimed AI moat real? Where is the hidden regulatory liability? What AI reps belong in the SPA? A two-to-four week engagement. Output structured for the deal team.
What we assess
The same assessment methodology applies to both use cases. The diligence variant adds moat verification and reps-and-warranties mapping on top of these six domains.
What is already deployed, what is in flight, what is proposed. The baseline no board paper actually contains today.
How each AI initiative maps to business objectives, and where build-vs-buy-vs-partner decisions are being made on weak foundations.
Expected return net of compliance, operational, and reputational cost. The number the CFO actually needs to sign the paper.
Which pilots will actually scale, which are stuck in proof-of-concept purgatory, and which should be retired before more capital is committed.
Which initiatives carry the highest write-off, regulatory, or reputational risk. The Agentic Risk Score applied across the portfolio.
Applicable regulatory requirements per initiative: Quebec Loi 25, Bill C-27 and AIDA, SOC 2, ISO 27001, ISO 42001, and sector-specific contractual obligations.
The deliverable
At the end of an InvestLens AI engagement, you receive a structured document calibrated to your buyer context:
Why start here
Boards demand an AI strategy, not an AI policy
The document that gets approved at board level is an investment plan with risk-adjusted numbers — not a slide deck on AI opportunity. InvestLens AI produces exactly that.
Every downstream decision depends on this one
Compliance scope, control infrastructure, hiring — everything that follows is calibrated to the initiatives that are actually moving forward. Without InvestLens AI, the next stages optimize for the wrong program.
The Agentic Risk Score is an audit and insurance artifact
Cyber liability insurers, SOC 2 auditors, and R&W underwriters increasingly require AI governance documentation. The Agentic Risk Score serves all three — plus the board.
How we work
Four to eight weeks for the internal investment strategy variant, depending on portfolio size and stakeholder access. Two to four weeks for the investor due-diligence variant — deal timelines are tight and we work to them.
For internal engagements: a board-ready AI Investment Strategy document, plus a standalone executive summary. For investor engagements: an IC-grade diligence memo structured for deal counsel and investment committee consumption, plus a red-flag report and a reps & warranties appendix.
Yes. Diligence engagements typically coordinate with deal counsel on reps & warranties mapping and with the R&W underwriter on the AI exposure analysis. Internal engagements coordinate with external auditors on the compliance implications.
The investment plan identifies the initiatives moving forward. From there, the compliance framework for those initiatives is the scope of ComplianceCore, and the technical control infrastructure is the scope of GuardLayer. Each stage is separately scoped — no bundled commitment.
Yes. All engagements operate under NDA. For diligence variants, we coordinate with your deal counsel on information-barrier procedures where needed.
A 30-minute call to scope an InvestLens AI engagement — whether you are planning AI investments internally or diligencing an AI-exposed target.